Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 724 (ZNF724) is a predicted DNA-binding transcription factor belonging to the large family of zinc finger proteins, which are characterized by their zinc finger domains that mediate sequence-specific DNA binding and regulation of transcription, typically via RNA polymerase II[2][6]. ZNF724 is predicted to localize to the cell nucleus and function primarily in the regulation of gene expression[2][6]. As of now, there is no evidence supporting its role as a therapeutic target, nor are there disease-specific roles, interacting drugs, biomarker relevance, or safety concerns associated with this protein[2][6]. Some sources refer to it as ZNF724P, indicating possible past annotation as a pseudogene or uncertainty about its functional status[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 724 (ZNF724).